Fibricor FDA Approval History
FDA Approved: Yes (First approved August 14, 2009)
Brand name: Fibricor
Generic name: fenofibric acid
Dosage form: Tablets
Company: Mutual Pharmaceutical Company, Inc.
Treatment for: High Cholesterol, Hypertriglyceridemia
Fibricor (fenofibric acid) is a peroxisome proliferator receptor alpha (PPARα) activator indicated to reduce triglyceride levels in patients with severe hypertriglyceridemia, and to reduce elevated total cholesterol, LDL, and increase HDL in patients with primary hyperlipidemia or mixed dyslipidemia.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.